date:Apr 28, 2012
, and protection against Alzheimers.
Study details
The Spanish researchers recruited 75 people receiving statins as primary prevention of CVD to participate in their triple-blinded, randomized, parallel, dose-response, placebo-controlled, follow-up trial.
Participants received either a resveratrol-rich grape supplement (resveratrol 8 mg), a conventional resveratrol-free grape supplement resveratrol, or placebo (maltodextrin) for six months, and then double the dose for the next six months.
Resul